4 August 2025
| Younghoon Kim, David J Hernstadt
|
EYE - General
Why do an ophthalmology elective? An elective in ophthalmology can offer a unique opportunity to delve deeper into the highly competitive specialty beyond the confines of the medical school curriculum, while experiencing a healthcare system in a new cultural setting....
A study led by researchers at Moorfields Eye Hospital and UCL Institute of Ophthalmology examined 36 ‘artificial intelligence as a medical device’ tools approved by regulators in Australia, Europe and the US, identifying that 19% had no published peer-reviewed data...
Organising a national teaching series is both deeply rewarding and surprisingly complex. It requires more than just good content – it demands a well-thought-out purpose, seamless logistics, strong communication and meaningful evaluation. Over the past year, I had the opportunity...
Securing funding for an educational or research initiative in ophthalmology can often feel like a competitive, confusing and time-intensive task. Whether you’re an early-career researcher looking to get your first project off the ground or an experienced educator aiming to...
Finally, even staunch sceptics are coming around to recognising that climate change is real and that we should do something about it. But how proximal the threat is and at what pace change has to happen is not universally agreed...
I was just coming to the end of a fantastic glaucoma fellowship at Moorfields, during which Samad Ansari had been a colleague and friend, and soon to start as a consultant in Oxford where Rebecca Turner is Clinical Director, and...
Herein we report two cases of toxic anterior segment syndrome (TASS) following uneventful cataract surgery. Both patients presented 24 hours after their uneventful operations with painless blurred vision in the operated eye. The inflammatory reaction was controlled successfully with an...
Abdul Muhyemin Tarin reviews the presentation, pathophysiology and management of this paraneoplastic syndrome. Case presentation A 60-year-old hypermetropic female patient presented with several months’ history of painless blurred vision. Visual acuity (VA) was 6/24 and 6/9-1 in right and left...
1 April 2015
| Keith Barton, Winifred Nolan, Nick Strouthidis
|
EYE - Glaucoma
Management options and outcomes in glaucoma practice were reviewed at the 7th Moorfields International Glaucoma Symposium, held in London on 24 January 2015. This article summarises perspectives from international glaucoma specialists on debated issues in topical therapy, glaucoma surgery, diagnostic...
Treatment options recommended by the National Institute for Health and Care Excellence (NICE) must be readily available for use in the NHS of England and Wales. This article provides an overview of recent guidance from NICE and summary advice issued...
Diabetic macular oedema (DMO) is a common complication associated with diabetic retinopathy, and the most common cause of visual impairment in diabetes [1]. With predicted rising levels of diabetes (in England by 2025 the estimated population with diabetes will be...
The goal of glaucoma management is to prevent visual loss and disease progression in the patient’s lifetime through effective lowering of intraocular pressure (IOP), the primary modifiable risk factor in glaucoma. Sustained and consistent IOP reduction is key to halting...